Adherence to medication in patients with rheumatoid arthritis is low, varying from 30 to 80%.
Improving adherence to therapy could therefore dramatically improve the efficacy of drug …

… Leendertse AJ, Visser D, Egberts AC, van den Bemt PM. The relationship between study
characteristics and the prevalence of medication-related hospitalizations: a literature review …

… Patricia van den Bemt and Bart van den Bemt were involved in development of the study.
All authors interpreted the data and reviewed the manuscript for critical content and editing. …

Objective To evaluate whether a disease activity guided strategy of dose reduction of two
tumour necrosis factor (TNF) inhibitors, adalimumab or etanercept, is non-inferior in …

… van den Bemt has received speaking fees from Pfizer, AbbVie, Sandoz, and UCB (less than
$10,000 each). Dr. van den Hoogen has received consulting fees and/or speaking fees from …

… Borgsteede SD, Karapinar-Çarkit F, Hoffmann E, Zoer J, van den Bemt PM. Information
needs about medication according to patients discharged from a general hospital. Patient Educ …

Review of the evidence on patient-centred care (PCC) in rheumatoid arthritis (RA) shows
that involving the patient as an individual – with unique needs, concerns and preferences – …

… van den Bemt has received speaking fees from Pfizer, AbbVie, Sandoz, and UCB (less than
$10,000 each). Dr. van den Hoogen has received consulting fees and/or speaking fees from …

… Bart van den Bemt: Dr. Van den Bemt supervised the conceptualization, design and data
analysis of the study, reviewed the manuscript and approved the final version as submitted. …

Background Medication nonadherence leads to suboptimal treatment outcomes, making it a
major priority in health care. eHealth provides an opportunity to offer medication adherence …